The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Share News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Kainos Exec Sells GBP4 Million In Shares

Wed, 05th Aug 2020 15:57

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

----------

Kainos Group PLC - Belfast-based digital services and platforms for government and commercial customers - Paul Gannon, senior vice president of business development, sells 400,000 shares at average GBP10.98, worth GBP4.4 million, on Wednesday. Now interested in 7.5 million shares, a 6.2% stake.

----------

Knights Group Holdings PLC - Staffordshire, England-based legal and professional services - Mark Beech, director of client services, sells 250,000 shares at GBP3.95, worth GBP987,500, on July 29.

----------

Volex PLC - Basingstoke, England-based connectivity and power products maker - Sharon Molloy, wife of Chief Operating Officer John Molloy, buys 98,561 shares at 137p, worth GBP135,029, on Wednesday. COO Molloy now interested in 1.3 million shares, a 0.8% stake.

----------

Senior PLC - Hertfordshire-based engineering firm for aerospace, defence, land vehicle and power & energy markets - Chair Ian King buys 207,000 shares at 48.27p, worth GBP99,919, on Tuesday. Now has 414,297 shares. Chief Executive David Squires buys 50,000 shares at 49.19p, worth GBP24,595, also on Tuesday. Now has 394,377 shares.

----------

NWF Group PLC - Cheshire-based distributor of fuel, feed and food - Julie Andrew, an associate of Company Secretary Rob Andrew, sells 10,000 shares at 209.1p, worth GBP20,910, on Tuesday. Rob Andrew now interested in 127,667 shares.

----------

Mereo Biopharma Group PLC - London-based clinical-stage biopharmaceutical firm - Chief Executive Officer Denise Scots-Knight buys 10,563 American Depositary Shares at USD2.85 per ADS, worth USD30,105, on July 31. Each ADS listed on Nasdaq equals five Mereo shares.

----------

Crest Nicholson Holdings PLC - Chertsey, Surrey-based housebuilder - Sally Nicholson, associate of COO Tom Nicholson, buys 11,000 shares at GBP1.86, worth GBP20,466, on Tuesday.

----------

Power Metal Resources PLC - exploring for gold in North America and Australia and for base metals in Africa - CEO Paul Johnson buys 1.4 million shares, directly and via Value Generation Ltd, at average 1.13p, worth GBP15,775, on Wednesday. Now holds 55.0 million shares, a 7.1% stake.

----------

Energean PLC - gas exploration and production in Mediterranean - Vassilis Tsetoglou, health & safety director, sells 2,000 shares at GBP5.80, worth GBP11,590, on Monday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Sep 2019 11:53

Mereo BioPharma Loss Narrows On Gain From OncoMed Buy And Expenses

(Alliance News) - Mereo BioPharma Group PLC on Tuesday posted a slightly narrowed loss for the first half of 2019 on a gain from its OncoMed Pharmaceuticals Inc acquisition, as well as lower in at

Read more
16 Aug 2019 15:32

DIRECTOR DEALINGS: Mereo BioPharma Trio Of Directors Acquire Shares

(Alliance News) - Mereo BioPharma Group PLC on Friday said General Counsel Charles Sermon, Chief Executive Officer Denise Scots-Knight and Head of Corporate Development John Richard, all purchased

Read more
16 Jul 2019 14:46

Mereo BioPharma Names Richard Francis As New Pharmaceutical Head

(Alliance News) - Mereo BioPharma has appointed Richard Francis as the new head of pharmaceutical development, effective August 1, the biopharmaceutical company said on Tuesday.Francis was

Read more
12 Jun 2019 16:04

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 JuneTescoWM Morrison SupermarketsSirius MineralsJust Jack 14 Evans 17 18

Read more
30 May 2019 10:52

Mereo BioPharma Reports Positive Data For Anti-Sclerostin Antibody

LONDON (Alliance News) - Mereo BioPharma Group PLC on Thursday reported positive six-month data for its anti-sclerostin antibody, BPS-804, in the treatment of adult patients with osteogenesis were

Read more
30 May 2019 10:40

Mereo BioPharma releases 'encouraging' data from setrusumab study

(Sharecast News) - Clinical stage biopharmaceutical company Mereo BioPharma Group announced encouraging six-month data from the open label arm of its phase 2b dose-ranging clinical study in adults with type I, III or IV osteogenesis imperfecta (OI) treated with BPS-804 ('setrusumab'), or the 'ASTEROID' study, on Thursday.

Read more
23 May 2019 17:58

DIRECTOR DEALINGS: Mereo Biopharma Non-Executive Bains Buys Shares

LONDON (Alliance News) - Mereo Biopharma PLC said Thursday that Non-Executive Director Peter Bains purchased around GBP42,750 in stock in a deal on Tuesday.Bains bought 47,500 shares at a

Read more
29 Apr 2019 12:05

Mereo BioPharma Set For Transformational 2019 As Loss Narrows Sharply

LONDON (Alliance News) - Mereo BioPharma Group PLC on Monday said its loss narrowed in 2018 following the completion of several product trials.The clinical stage biopharmaceutical company a

Read more
23 Apr 2019 14:48

Mereo BioPharma Completes Merger With OncoMed Pharmaceuticals

LONDON (Alliance News) - Mereo BioPharma Group PLC on Tuesday said its all-stock merger with OncoMed Pharmaceuticals Inc is now complete.OncoMed's shareholders approved the deal on last

Read more
18 Apr 2019 11:37

OncoMed Shareholders Approve All-Share Merger With Mereo BioPharma

LONDON (Alliance News) - Mereo BioPharma Group PLC on Thursday said OncoMed Pharmaceuticals Inc shareholders have approved the merger of the two companies.Mereo BioPharma, a clinical stage

Read more
15 Apr 2019 10:07

Mereo Agrees With US FDA On Phase Three Trial Design For Acumapimod

LONDON (Alliance News) - Mereo BioPharma Group PLC said on Monday it has concluded an end of Phase Two meeting with the US Food & Drug Administration regarding acumapimod as a treatment for of

Read more
15 Mar 2019 16:57

Mereo BioPharma Scures Further Acceptances From OncoMed Shareholders

LONDON (Alliance News) - Mereo BioPharma Group PLC on Friday said it has now received support agreements in respect of 21.1% of OncoMed Pharmaceuticals Inc's shares and expects to complete the

Read more
15 Mar 2019 15:16

Mereo BioPharma merger with OncoMed moves closer

(Sharecast News) - Clinical-stage biopharmaceutical company Mereo BioPharma Group updated the market on its proposed combination with OncoMed Pharmaceuticals on Friday, which it said should close in the second quarter of 2019.

Read more
22 Feb 2019 14:35

Mereo BioPharma Withdraws US Listing Application On OncoMed Deal (ALLIPO)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Friday it has requested the withdrawal of its US IPO application as it continues to work on its business combination with US pharmaceutical

Read more
11 Feb 2019 12:44

Mereo BioPharma Founding Director Departs Before OncoMed Combination

LONDON (Alliance News) - Mereo BioPharma Group PLC on Monday announced the immediate departure of founding board director Frank Armstrong prior to Mereo's combination with US firm OncoMed was

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.